PFIZER INC - Research Update.

PR Newswire UK Disclose, March, 2007

 
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart 
                                   Disease 
 
  The Only-Approved Cholesterol-Lowering Medication for Reducing the Risk of 
                      Hospitalization for Heart Failure 
 
    NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug 
Administration (FDA) has approved Lipitor(R) (atorvastatin calcium) Tablets to 
reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain 
types of heart surgery, hospitalization for heart failure, and chest pain in 
patients with heart disease.  Lipitor is the first cholesterol-lowering 
medication to receive FDA approval for the reduction of the risk of 
hospitalization for heart failure. 
    This new approval expands the...

            
        
    
    	    
                
                
	

		

					 
            Read the rest of this article with a Free Trial at HighBeam Research.
        				
 

    		            
	
                Premium Content Partnership | 
                	HighBeam Research provides an in-depth online archive library of reference works.